• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • español 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Login
Ver ítem 
  •   DSpace Principal
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Ver ítem
  •   DSpace Principal
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.
Todo DSpace
  • Comunidades & Colecciones
  • Por fecha de publicación
  • Autores
  • Títulos
  • Materias

Historical hallmarks of anticoagulation and antiplatelet agents

Thumbnail
Autor
Tsoucalas G., Chevallier J., Karamanou M., Papaioannou T., Sgantzos M., Androutsos G.
Fecha
2016
Language
en
DOI
10.2174/1381612822666160111124615
Materia
acetylsalicylic acid
anticoagulant agent
antithrombocytic agent
clopidogrel
dicoumarol
heparin
hirudin
pentosan polysulfate
streptokinase
ticagrelor
ticlopidine
urokinase
warfarin
anticoagulant agent
antithrombocytic agent
anticoagulation
Article
bleeding disorder
blood clotting
disease severity
drug acetylation
fibrinolysis
human
nonhuman
priority journal
thrombocyte function
thromboembolism
thrombosis
drug effects
history
thrombosis
Anticoagulants
Blood Coagulation
History, 19th Century
History, 20th Century
History, 21st Century
Humans
Platelet Aggregation Inhibitors
Thrombosis
Bentham Science Publishers B.V.
Mostrar el registro completo del ítem
Resumen
Thrombosis is a well known phenomenon among physicians since antiquity. A variety of peculiar agents, such as leeches and bark, were used to prevent it. Hirudin was used during the 19th century. The next eon, heparin, strepokinase, urokinase, TPA, dicumarol, warfarin, aspirin, ticlopidine, Clopidogrel, SSHA and SP54 provoked huge advances in anticoagulation. During 21st century with the use of fondaparinux, dabigatran, rivaroxaban and Ticagrelor antithrombotic prevention and therapeutic interaction entered an era of medical challenges. Although the risk after a thrombotic episode is now highly reduced, blood clots still present damaging or even lethal consequences in human organisms and further research is strongly recommended. © 2016 Bentham Science Publishers.
URI
http://hdl.handle.net/11615/80110
Colecciones
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]

Ítems relacionados

Mostrando ítems relacionados por Título, autor o materia.

  • Thumbnail

    Antithrombotic therapy for elderly patients with acute coronary syndrome: Reasons to be cautious 

    Kotsiou O.S., Xirogiannis I.K. (2020)
    [No abstract available]
  • Thumbnail

    Patterns in the management of superficial vein thrombosis 

    Karathanos C., Spanos K., Lachanas V., Athanasoulas A., Giannoukas A.D. (2017)
    Objective: To highlight current practice patterns in management of superficial vein thrombosis. Methods: An electronic survey was conducted using the mailing lists of the Mediterranean League of Angiology and Vascular ...
  • Thumbnail

    Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: Updated systematic review and meta-analysis 

    Ntaios G., Papavasileiou V., Sagris D., Makaritsis K., Vemmos K., Steiner T., Michel P. (2018)
    Background and Purpose: Previous systematic reviews and meta-analyses compared the efficacy and safety of patent foramen ovale (PFO) closure versus medical treatment in patients with cryptogenic stroke or transient ischemic ...
htmlmap 

 

Listar

Todo DSpaceComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasEsta colecciónPor fecha de publicaciónAutoresTítulosMaterias

Mi cuenta

AccederRegistro
Help Contact
DepositionAboutHelpContacto
Choose LanguageTodo DSpace
EnglishΕλληνικά
htmlmap